Sumitomo Dainippon Pharma Co. Ltd Financials

Market Capitalization ¥218.51 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-0.75
Forward PE	32.11
Price to Sales TTM	¥0.64
Price to Book MRQ	¥1.91
Enterprise to Revenue	1.49
Enterprise to EBITDA	-2.09

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-03-31
Profit Margin	-81.55%
Operating Margin	-5.63%
Return on Assets TTM	-17.76%
Return on Equity TTM	-106.19%

Income Statement

Revenue TTM	¥342,665,003,008
Revenue per Share TTM	¥862.51
Quarterly Revenue Growth	17.00%
Gross Profit TTM	¥204,084,002,816
EBITDA	¥-244,022,001,664
Net Income to Common TTM	¥-279,457,005,568
Diluted EPS TTM	¥-703.40
Quarterly Earnings Growth YoY	-16.53%

Balance Sheet

Total Cash MRQ	¥99,082,002,432
Total Cash per Share MRQ	¥249.39
Total Debt MRQ	¥
Total Debt to Equity MRQ	340.83
Current Ratio MRQ	0.64
Book Value per Share MRQ	¥287.37

Cash Flow

Operating Cash Flow TTM	¥-62,843,998,208
Levered Free Cash Flow TTM	¥-173,980,123,136

4506 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	397,289,984
Float Shares	180,063,904
Avg 10 Volume	1,525,990
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	57.45%
% Held by Institutions	17.63%

Stock Price Summary

Beta	0.63
Fifty Two Week Low	¥279.00
Fifty Two Week High	¥692.00
Fifty Two Week Change	23.23%
Day 50 MA	¥578.26
Day 200 MA	¥499.99

Dividends and Splits

Forward Annual Dividend Rate	¥14.00
Forward Annual Dividend Yield	2.36%
Trailing Annual Dividend Rate	¥21.00
Trailing Annual Dividend Yield	3.54%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2023-03-30
Last Split Factor
Last Split Date